A continuous glucose monitor (CGM) is a small sensor under the skin that reads glucose around the clock and sends real-time readings, trends and high or low alerts to a receiver or phone. That stream shows how glucose responds to food and medication, replaces most fingersticks, and cuts the risk of hypoglycemia and long-term diabetes complications.
Summary: As technology improves and sensors become smaller, continuous glucose monitoring (CGM) is emerging as the next big thing in diabetes management. It has several benefits over the traditional ways of blood glucose level monitoring. First, it provides much more abundant data showing how blood glucose levels change in response to food and medications. Thus, it helps provide much better care and reduces the risk of both acute and chronic diabetes complications.
Diabetes is a chronic disease that affects millions of people worldwide. According to the International Diabetes Federation (IDF), there are currently more than 500 million adults aged 20-79 living with diabetes globally. This number is projected to increase to 700 million by 2045. In the United States, over 34 million people, or 10.5% of the population, have diabetes, with an estimated 88 million more adults having prediabetes. Diabetes is a significant health problem and a leading cause of death and disability worldwide. Diabetes is a condition that affects the body’s ability to produce or use insulin. Insulin is a hormone that regulates blood glucose levels. Uncontrolled high blood glucose levels can lead to complications such as heart disease, stroke, kidney disease, and vision loss. Diabetes can be managed through lifestyle changes such as diet and exercise, medication, and self-monitoring of blood glucose levels. Blood glucose monitoring is an integral part of diabetes management. It not only helps reduce the risk of acute and chronic diabetes complications but also helps optimize treatment. Though blood glucose monitoring is vital for anyone living with diabetes, it is especially useful for those living with moderate to severe diabetes. In addition, it is particularly vital for those using insulin for diabetes management, as it may help prevent life-threatening complications like hypoglycemia. Self-monitoring of blood glucose (SMBG) is essential to diabetes management. It involves using a glucometer to measure blood glucose levels at home. SMBG helps people with diabetes make informed decisions about diet, exercise, and medication and can help them identify patterns and trends in their blood glucose levels. Continuous glucose monitoring (CGM) is a relatively new technology revolutionizing diabetes management. CGM involves using a small sensor placed under the skin to monitor glucose levels continuously. The sensor measures interstitial glucose levels, which reflect glucose levels in the bloodstream. The sensor sends data to a receiver or smartphone app, which displays real-time glucose readings, trends, and alerts. CGM is an improvement over traditional SMBG because it provides more comprehensive data about glucose levels, including trends and patterns that can help people with diabetes make more informed decisions about diet, exercise, and medication. CGM can also provide alerts for high or low glucose levels, reducing the risk of hypoglycemia or hyperglycemia. There are several features that make CGM superior to traditional SMBG. First, CGM provides more comprehensive data about glucose levels, including trends and patterns that can help people with diabetes identify and address issues before they become problematic. Second, CGM can provide real-time alerts for high or low glucose levels, reducing the risk of hypoglycemia or hyperglycemia. Third, CGM can help people with diabetes make more informed decisions about diet, exercise, and medication, leading to better overall glucose control. Some unique benefits of CGM are: Improved glucose control: Continuous glucose monitoring (CGM) provides people with diabetes with real-time information about their glucose levels, allowing them to make more informed decisions about diet, exercise, and medication. This can lead to better glucose control and reduced risk of complications associated with high or low glucose levels. Enhanced safety: CGM can help reduce the risk of hypoglycemia and hyperglycemia by providing real-time alerts for high or low glucose levels. This is especially important for people at risk of severe hypoglycemia or who have difficulty recognizing the symptoms of hypoglycemia. Improved quality of life: CGM can enhance the quality of life for people with diabetes by reducing the need for frequent fingerstick testing and allowing for greater flexibility in daily activities, such as exercise and travel. Better sleep: CGM can also help people with diabetes get better sleep by providing information about glucose levels during the night. This can help reduce the risk of nocturnal hypoglycemia and provide peace of mind for people who are concerned about their glucose levels during sleep. Cost-effective: Despite the initial cost of the device and sensors, CGM has been shown to be cost-effective in the long run, especially for people with poorly controlled diabetes who are at risk of complications. CGM can help reduce healthcare costs associated with hospitalization, emergency room visits, and long-term complications of diabetes. There are several gadgets currently available for continuous glucose monitoring, including devices from Dexcom, Medtronic, and Abbott. These devices consist of a small sensor placed under the skin and a receiver or smartphone app that displays glucose readings, trends, and alerts. Some devices also offer additional features, such as insulin pump integration or the ability to share data with healthcare providers or family members. There is a growing perspective that CGM will soon be available as part of wearables, such as smartwatches. Companies like Apple and Google are investing in health monitoring technologies. They have already added features like heart rate monitoring and ECG to their smartwatches. CGM technology could be the next logical step in the evolution of wearables, providing people with diabetes with real-time glucose data and alerts on their wrists. In summary, diabetes is a significant global health problem affecting millions worldwide. Self-monitoring of blood glucose (SMBG) is essential to diabetes management, allowing people with diabetes to make informed decisions about diet, exercise, and medication. Continuous glucose monitoring (CGM) is a relatively new technology revolutionizing diabetes management, providing more comprehensive data about glucose levels and real-time alerts for high or low glucose levels. CGM is superior to traditional SMBG because it provides more comprehensive data and real-time alerts.
Frequently asked questions
How does a continuous glucose monitor work?
A small sensor sits just under the skin and measures interstitial glucose, the sugar in the fluid around your cells, which reflects the level in your bloodstream. The sensor sends that data around the clock to a receiver or a smartphone app. The screen shows real-time readings, trend lines and alerts when glucose runs too high or too low.
What are the benefits of a continuous glucose monitor?
A CGM shows how your glucose responds to food, exercise and medication, instead of one snapshot at a time. That fuller picture drives better glucose control and fewer complications. Real-time alerts cut the risk of dangerous lows and highs, overnight readings guard against low blood sugar during sleep, and far fewer finger pricks make exercise and travel easier.
Does a CGM replace fingerstick testing?
For most daily checks, yes. Traditional self-monitoring uses a glucometer and a finger prick at home, and each prick captures a single moment. A CGM reads glucose continuously, so it removes the need for frequent fingerstick tests and adds the trends, patterns and alerts that a single reading cannot give you.
Who benefits most from a continuous glucose monitor?
Anyone living with diabetes gains from glucose monitoring, but a CGM matters most for people with moderate to severe or poorly controlled diabetes and for people who use insulin. It is especially important if you are at risk of severe low blood sugar or have trouble recognizing the warning signs, because the real-time alerts flag a low for you.
Which companies make continuous glucose monitors?
Dexcom, Medtronic and Abbott all make CGM systems. Each pairs a small sensor under the skin with a receiver or smartphone app that displays readings, trends and alerts. Some connect to an insulin pump or share data with your healthcare provider or family. Apple and Google are investing in health monitoring, and glucose readings on a smartwatch are the logical next step.
Dr. Gurpreet Singh Padda, MD, MBA, MHP
